Replimune REPL
NASDAQ REPL
$13.00 +0.44 (+3.50%)
At close: Sep 29, 2026 · 4:00 PM EDT

Replimune (REPL) Assets (2018 - 2026)

Updated

Replimune (REPL) recorded Assets of $252.45 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 46.2% from $469.51 million a year earlier and down 24.1% from the prior quarter.

Analysis

Replimune (REPL) Assets (2018 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Replimune reported Assets of $332.39 million, down 39.7% from FY2025.

  • Annual Assets has a five-year compound annual growth rate of -9.4% (FY2021 to FY2026).
  • Across earlier fiscal years, Assets came in at $551.33 million in FY2025 (+13.0%), $487.72 million in FY2024 (-24.6%), $646.59 million in FY2023 (+40.2%) and $461.19 million in FY2022 (-15.1%).
  • The fiscal Q1 2027 figure is the lowest quarterly Assets since fiscal Q4 2020.
  • On a year-over-year basis, Assets has declined for five consecutive quarters, with an average decline of 18.7% over the last eight quarters.
  • Peak year-over-year performance for Assets in the last five years was growth of 60.2% in fiscal Q2 2022, against a decline of 46.2% in fiscal Q1 2027 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $332.39 million (Q4 2026), $333.59 million (Q3 2026) and $389.45 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Replimune 1.05 Bn 1.05 Bn - 252.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 252.45 Mn
Mar 31, 2026 332.39 Mn
Dec 31, 2025 333.59 Mn
Sep 30, 2025 389.45 Mn
Jun 30, 2025 469.51 Mn
Mar 31, 2025 551.33 Mn
Dec 31, 2024 603.63 Mn
Sep 30, 2024 498.20 Mn
Jun 30, 2024 534.97 Mn
Mar 31, 2024 487.72 Mn
Dec 31, 2023 532.93 Mn
Sep 30, 2023 562.40 Mn
Jun 30, 2023 603.89 Mn
Mar 31, 2023 646.59 Mn
Dec 31, 2022 678.55 Mn
Sep 30, 2022 436.10 Mn
Jun 30, 2022 459.43 Mn
Mar 31, 2022 461.19 Mn
Dec 31, 2021 485.28 Mn
Sep 30, 2021 503.46 Mn
API Access

Replimune Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=REPL&period=max&api_key=YOUR_API_KEY